An Optimized Full-Length FLT3/CD3 Bispecific Antibody Demonstrates Potent Anti-leukemia Activity and Reversible Hematological Toxicity

FLT3 (FMS-like tyrosine kinase 3), expressed on the surface of acute myeloid leukemia (AML) blasts, is a promising AML target, given its role in the development and progression of leukemia, and its limited expression in tissues outside the hematopoietic system. Small molecule FLT3 kinase inhibitors...

詳細記述

保存先:
書誌詳細
出版年:Mol Ther
主要な著者: Yeung, Yik Andy, Krishnamoorthy, Veena, Dettling, Danielle, Sommer, Cesar, Poulsen, Kris, Ni, Irene, Pham, Amber, Chen, Wei, Liao-Chan, Sindy, Lindquist, Kevin, Chin, S. Michael, Chunyk, Allison Given, Hu, Wenyue, Sasu, Barbra, Chaparro-Riggers, Javier, Djuretic, Ivana
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Gene & Cell Therapy 2020
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7054815/
https://ncbi.nlm.nih.gov/pubmed/31981494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2019.12.014
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料